1st Quarter - Report

PRIME THERAPEUTICS for PRIME THERAPEUTICS

Firm
Client
Income
—
Expenses
$90,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S.1339: "Pharmacy Benefit Manager Reform Act," provisions related to disclosure, audits and PBM contracting. Proposed amendments to S.1339 creating a default spread pricing option with options to elect pass-through payments for PBM compensation. S.3548: "Health Care Prices Revealed and Information to Consumers Explained Transparency Act," a bill to amend the Public Health Services Act to provide for hospital and insurer price transparency. H.R.5378: "Lower Costs, More Transparency Act," provisions related to PBM transparency and disclosure requirements. S.1542/H.R.6283: "The Delinking Revenue from Unfair Gouging (DRUG) Act," provisions dictating PBM contracting terms. S.127: Pharmacy Benefit Manager Transparency Act of 2023, a bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.

LobbyistCovered position, as disclosed
JULIE CAROL CANTOR-WEINBERG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6283 (118th), S. 3548 (118th), S. 1542 (118th), H.R. 5378 (118th), S. 127 (118th), S. 1339 (118th)

Medicare/Medicaid MMM

S.3430: "Better Mental Healthcare, Lower Cost Drugs & Extenders Act," provisions related to PBMs and pharmacy contracting. S.2973: "Modernizing and Ensuring PBM Accountability Act," provisions related to PBM contracting, audits and disclosures. H.R.5526: "Seniors Access to Critical Medications Act of 2023," provisions clarifying Medicare so that delivery of medicines through various methods or by allowing a family member or caregiver to pick up medication on behalf of a patient does not violate the Stark Law and does fall within the scope of Stark's IOAS exception. H.R.7512: "Real-Time Benefit Tool Implementation Act," legislation to ensure implementation of real-time benefit tools under part D of the Medicare program. Implementation of Center for Medicare and Medicaid Services Final Rule, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Final Rule, CMS-4192-F, CMS-1744-F, provisions related to changes in Pharmacy Direct and Indirect Renumeration. Implementation of H.R. 5376 (117th Congress)/P.L. 117-169 "The Inflation Reduction Act," provisions related to changes in Medicare Part D and government negotiation of drug prices. S.2305: "Biosimilars Red Tape Elimination Act," provisions relating improving the requirements for making a determination of interchangeability of a biological product and its reference product.

LobbyistCovered position, as disclosed
JULIE CAROL CANTOR-WEINBERG —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 2305 (118th), S. 2973 (118th), H.R. 7512 (118th), S. 3430 (118th), H.R. 5376 (118th), H.R. 5526 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.